Fibrinogen-binding and platelet-aggregation activities of a Lactobacillus salivarius septicaemia isolate are mediated by a novel fibrinogen-binding protein

James Collins, Jan-Peter van Pijkeren, Lisbeth Svensson, Marcus J Claesson, Mark Sturme, Yin Li, Jakki C Cooney, Douwe van Sinderen, Alan W Walker, Julian Parkhill, Oonagh Shannon, Paul W O'Toole

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The marketplace for probiotic foods is burgeoning, measured in billions of euro per annum. It is imperative, however, that all bacterial strains are fully assessed for human safety. The ability to bind fibrinogen is considered a potential pathogenicity trait that can lead to platelet aggregation, serious medical complications, and in some instances, death. Here we examined strains from species frequently used as probiotics for their ability to bind human fibrinogen. Only one strain (CCUG 47825), a Lactobacillus salivarius isolate from a case of septicaemia, was found to strongly adhere to fibrinogen. Furthermore, this strain was found to aggregate human platelets at a level comparable to the human pathogen Staphylococcus aureus. By sequencing the genome of CCUG 47825, we were able to identify candidate genes responsible for fibrinogen binding. Complementing the genetic analysis with traditional molecular microbiological techniques enabled the identification of the novel fibrinogen receptor, CCUG_2371. Although only strain CCUG 47825 bound fibrinogen under laboratory conditions, homologues of the novel fibrinogen binding gene CCUG_2371 are widespread among L. salivarius strains, maintaining their potential to bind fibrinogen if expressed. We highlight the fact that without a full genetic analysis of strains for human consumption, potential pathogenicity traits may go undetected.
Original languageEnglish
Pages (from-to)862-877
Number of pages16
JournalMolecular Microbiology
Volume85
Issue number5
Early online date11 Jul 2012
DOIs
Publication statusPublished - Sep 2012

Fingerprint

Platelet Aggregation
Fibrinogen
Sepsis
Carrier Proteins
Probiotics
Virulence
Microbiological Techniques
Fibrinogen Receptors
Lactobacillus salivarius
Genes
Staphylococcus aureus
Blood Platelets
Genome
Safety
Food

Keywords

  • adhesins, bacterial
  • bacterial proteins
  • fibrinogen
  • fibronectins
  • genome, bacterial
  • humans
  • Lactobacillus
  • platelet aggregation
  • probiotics
  • protein binding

Cite this

Fibrinogen-binding and platelet-aggregation activities of a Lactobacillus salivarius septicaemia isolate are mediated by a novel fibrinogen-binding protein. / Collins, James; van Pijkeren, Jan-Peter; Svensson, Lisbeth; Claesson, Marcus J; Sturme, Mark; Li, Yin; Cooney, Jakki C; van Sinderen, Douwe; Walker, Alan W; Parkhill, Julian; Shannon, Oonagh; O'Toole, Paul W.

In: Molecular Microbiology, Vol. 85, No. 5, 09.2012, p. 862-877.

Research output: Contribution to journalArticle

Collins, J, van Pijkeren, J-P, Svensson, L, Claesson, MJ, Sturme, M, Li, Y, Cooney, JC, van Sinderen, D, Walker, AW, Parkhill, J, Shannon, O & O'Toole, PW 2012, 'Fibrinogen-binding and platelet-aggregation activities of a Lactobacillus salivarius septicaemia isolate are mediated by a novel fibrinogen-binding protein', Molecular Microbiology, vol. 85, no. 5, pp. 862-877. https://doi.org/10.1111/j.1365-2958.2012.08148.x
Collins, James ; van Pijkeren, Jan-Peter ; Svensson, Lisbeth ; Claesson, Marcus J ; Sturme, Mark ; Li, Yin ; Cooney, Jakki C ; van Sinderen, Douwe ; Walker, Alan W ; Parkhill, Julian ; Shannon, Oonagh ; O'Toole, Paul W. / Fibrinogen-binding and platelet-aggregation activities of a Lactobacillus salivarius septicaemia isolate are mediated by a novel fibrinogen-binding protein. In: Molecular Microbiology. 2012 ; Vol. 85, No. 5. pp. 862-877.
@article{d9eb3a06e5d44de98cc4e3a1274a878a,
title = "Fibrinogen-binding and platelet-aggregation activities of a Lactobacillus salivarius septicaemia isolate are mediated by a novel fibrinogen-binding protein",
abstract = "The marketplace for probiotic foods is burgeoning, measured in billions of euro per annum. It is imperative, however, that all bacterial strains are fully assessed for human safety. The ability to bind fibrinogen is considered a potential pathogenicity trait that can lead to platelet aggregation, serious medical complications, and in some instances, death. Here we examined strains from species frequently used as probiotics for their ability to bind human fibrinogen. Only one strain (CCUG 47825), a Lactobacillus salivarius isolate from a case of septicaemia, was found to strongly adhere to fibrinogen. Furthermore, this strain was found to aggregate human platelets at a level comparable to the human pathogen Staphylococcus aureus. By sequencing the genome of CCUG 47825, we were able to identify candidate genes responsible for fibrinogen binding. Complementing the genetic analysis with traditional molecular microbiological techniques enabled the identification of the novel fibrinogen receptor, CCUG_2371. Although only strain CCUG 47825 bound fibrinogen under laboratory conditions, homologues of the novel fibrinogen binding gene CCUG_2371 are widespread among L. salivarius strains, maintaining their potential to bind fibrinogen if expressed. We highlight the fact that without a full genetic analysis of strains for human consumption, potential pathogenicity traits may go undetected.",
keywords = "adhesins, bacterial, bacterial proteins, fibrinogen, fibronectins, genome, bacterial, humans, Lactobacillus, platelet aggregation, probiotics, protein binding",
author = "James Collins and {van Pijkeren}, Jan-Peter and Lisbeth Svensson and Claesson, {Marcus J} and Mark Sturme and Yin Li and Cooney, {Jakki C} and {van Sinderen}, Douwe and Walker, {Alan W} and Julian Parkhill and Oonagh Shannon and O'Toole, {Paul W}",
note = "{\circledC} 2012 Blackwell Publishing Ltd.",
year = "2012",
month = "9",
doi = "10.1111/j.1365-2958.2012.08148.x",
language = "English",
volume = "85",
pages = "862--877",
journal = "Molecular Microbiology",
issn = "0950-382X",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Fibrinogen-binding and platelet-aggregation activities of a Lactobacillus salivarius septicaemia isolate are mediated by a novel fibrinogen-binding protein

AU - Collins, James

AU - van Pijkeren, Jan-Peter

AU - Svensson, Lisbeth

AU - Claesson, Marcus J

AU - Sturme, Mark

AU - Li, Yin

AU - Cooney, Jakki C

AU - van Sinderen, Douwe

AU - Walker, Alan W

AU - Parkhill, Julian

AU - Shannon, Oonagh

AU - O'Toole, Paul W

N1 - © 2012 Blackwell Publishing Ltd.

PY - 2012/9

Y1 - 2012/9

N2 - The marketplace for probiotic foods is burgeoning, measured in billions of euro per annum. It is imperative, however, that all bacterial strains are fully assessed for human safety. The ability to bind fibrinogen is considered a potential pathogenicity trait that can lead to platelet aggregation, serious medical complications, and in some instances, death. Here we examined strains from species frequently used as probiotics for their ability to bind human fibrinogen. Only one strain (CCUG 47825), a Lactobacillus salivarius isolate from a case of septicaemia, was found to strongly adhere to fibrinogen. Furthermore, this strain was found to aggregate human platelets at a level comparable to the human pathogen Staphylococcus aureus. By sequencing the genome of CCUG 47825, we were able to identify candidate genes responsible for fibrinogen binding. Complementing the genetic analysis with traditional molecular microbiological techniques enabled the identification of the novel fibrinogen receptor, CCUG_2371. Although only strain CCUG 47825 bound fibrinogen under laboratory conditions, homologues of the novel fibrinogen binding gene CCUG_2371 are widespread among L. salivarius strains, maintaining their potential to bind fibrinogen if expressed. We highlight the fact that without a full genetic analysis of strains for human consumption, potential pathogenicity traits may go undetected.

AB - The marketplace for probiotic foods is burgeoning, measured in billions of euro per annum. It is imperative, however, that all bacterial strains are fully assessed for human safety. The ability to bind fibrinogen is considered a potential pathogenicity trait that can lead to platelet aggregation, serious medical complications, and in some instances, death. Here we examined strains from species frequently used as probiotics for their ability to bind human fibrinogen. Only one strain (CCUG 47825), a Lactobacillus salivarius isolate from a case of septicaemia, was found to strongly adhere to fibrinogen. Furthermore, this strain was found to aggregate human platelets at a level comparable to the human pathogen Staphylococcus aureus. By sequencing the genome of CCUG 47825, we were able to identify candidate genes responsible for fibrinogen binding. Complementing the genetic analysis with traditional molecular microbiological techniques enabled the identification of the novel fibrinogen receptor, CCUG_2371. Although only strain CCUG 47825 bound fibrinogen under laboratory conditions, homologues of the novel fibrinogen binding gene CCUG_2371 are widespread among L. salivarius strains, maintaining their potential to bind fibrinogen if expressed. We highlight the fact that without a full genetic analysis of strains for human consumption, potential pathogenicity traits may go undetected.

KW - adhesins, bacterial

KW - bacterial proteins

KW - fibrinogen

KW - fibronectins

KW - genome, bacterial

KW - humans

KW - Lactobacillus

KW - platelet aggregation

KW - probiotics

KW - protein binding

U2 - 10.1111/j.1365-2958.2012.08148.x

DO - 10.1111/j.1365-2958.2012.08148.x

M3 - Article

VL - 85

SP - 862

EP - 877

JO - Molecular Microbiology

JF - Molecular Microbiology

SN - 0950-382X

IS - 5

ER -